Rilvegostomig Antibody
Rilvegostomig is a humanized bispecific IgG1 antibody that simultaneously targets the PD-1 and TIGIT immune checkpoint receptors. It is designed to enhance T-cell activation and is investigated in preclinical and clinical research, particularly for applications in oncology such as non-small cell lung cancer (NSCLC) .
Product Specifications
Target
PD-1/PD-L1
Clonality
Recombinant
Conjugation
Unconjugated
Field of Research
Cell Biology, Immunology & Inflammation
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6405047-01 0.1 mL
ABCG4 (ATP-binding Cassette Sub-family G Member 4, WHITE2) (APC)
Sign In for Pricing
View Details MBS6405047-02 5x 0.1 mL
ABCG4 (ATP-binding Cassette Sub-family G Member 4, WHITE2) (APC)
Sign In for Pricing
View Details 
MBS1224906-01 0.02 mg (E-Coli)
Recombinant Escherichia coli O17:K52:H18 Peptide deformylase (def)
Sign In for Pricing
View Details MBS1224906-02 0.1 mg (E-Coli)
Recombinant Escherichia coli O17:K52:H18 Peptide deformylase (def)
Sign In for Pricing
View Details